StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > OMFUG! Am I Reading This Right??!!

<< Previous

Bullboard Posts

Next >>

Comment by LithLoveron Nov 09, 2021 9:28pm

151 Views

Post# 34107847

RE:RE:RE:RE:RE:RE:OMFUG! Am I Reading This Right??!!

Agree 100%. The deal was made when the sp was over $1. With even more shares the incentive to get the share price back to $1 and higher will be huge. They have relationships with health care companies and oncologists.

They will work hard to get this back up

molotov420 wrote: Doesn't really matter TBH. Gotta give them the shares so they have more skin in the game. The more they stand to gain from better performance the better for us shareholders.

<< Previous

Bullboard Posts

Next >>

BMO evolves InvestorLine with enhanced tools for options trading